Stay updated with breaking news from Integrated Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Multiple surveys of patient-reported outcomes from the phase 3 EMBARK trial revealed no meaningful differences in pain progression or urinary symptoms and bowel symptoms or function over 205 weeks of follow-up. Enzalutamide does not worsen health-related quality of life compared with androgen deprivation therapy in patients with high-risk biochemically recurrence nmCSPC.
In Meru county, environmental experts are sounding an alarm over the dwindling of water resources especially in the Mt Kenya ecosystem, one of Kenya's water towers.
Rice University today announced the addition of Kevin Sheridan to its external advisory board for the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discove
Enzalutamide plus androgen deprivation therapy or alone can extend metastasis-free survival and maintain quality of life in men with prostate cancer facing a high-risk for biochemical recurrence.
ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of the 2020 Nobel Prize in Chemistry for her pioneering work on CRISPR/Cas9, provides access to the definitive patent portfolio for this groundbreaking technology.